3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company
107 42% 132 97 36% Operating Cash Flow 240 249 258 (7)% 923 966 (4)% Net Operating Debt to Equity (times) 0.45 0.39 0.84 (46)% 0.45 0.84 (46)% 1Consolidated financials are based upon elimination of
results based on its audited consolidated financial statements ended 31 December 2017 as follows. Management’s Discussion and Analysis The following Management's Discussion and Analysis should be read in
, the total transaction value shall be equivalent to 39.91% calculated based on the Net Profit which is the basis that results in the highest transaction value, from the Consolidated Financial Statement
DISCUSSION AND ANALYSIS FOR PERIOD ENDED 30 SEPTEMBER 2017 3. Financial highlights (based on Thai FRS) Q3 2017 Financial Position Summary as of 30 September 2017 compared to Q3 2016: Q3 2017 Q3 2016 YoY change
and related assets in LPG trading business may less than carrying value. The estimation of recoverable amount based on value in use was lower than net book value. However, allowance for doubtful account
rate. The increase of property, plant and equipment was due to the investment in MRI and Hemodialysis Centers and renovation of building at the beginning of this year. Financial Position : Consolidated
subsidiary in 1Q’18. Social Security Office’s trade receivable increased which was in line with more registered persons. The increase of property, plant and equipment was due to the investment in MRI and
% Income tax income (expenses) 619 0.17% 1,787 0.91% (1,168) 65.36% Profit (loss) for the period 33,861 9.27% (22,064) 11.24% 55,925 253.47% Remark: Financial ratio is based on common-size analysis to total